Schwendenman Andrew sold $99K of REPL
Schwendenman Andrew (Chief Accounting Officer) sold 7,632 shares of Replimune Group, Inc. (REPL) at $12.97 on 2026-08-10.
How this was made
The 30-second read
Why it matters
The newest fact is the CFO’s open-market sale details (shares, price, total value, and post-transaction holdings). No operational or financial updates are provided.
Market read
Traders may note the insider sale as a small sentiment datapoint, but there is no fundamental catalyst in the filing.
What to watch
Insider sales can be scheduled around personal events and do not reflect forward-looking valuation unless paired with other disclosures (guidance changes, financing, litigation, or clinical/regulatory milestones).
Background
The article is an SEC Form 4 insider transaction disclosure for Replimune Group, Inc.
Ticker impact
Replimune Group disclosed an insider open-market sale by CFO Andrew Schwendenman of 7,632 shares at $12.97 on Aug. 10.
Low likelihood of a sustained price move; any reaction is likely brief and sentiment-driven.
The filing is a primary-source insider transaction, but it does not include new company performance, guidance, or regulatory/contract developments. The disclosed sale size is also relatively small versus typical market-moving thresholds.
Market effects
Minimal. Insider-sale Form 4s rarely reset sector expectations without accompanying company-specific news.
None indicated.
None indicated.
Counterpoint
The absence of a 10b5-1 plan does not necessarily imply bearish intent; insiders may sell for diversification, taxes, or planned personal liquidity needs.
Key entities
- issuerReplimune Group, Inc.
Company whose insider transaction was disclosed on Form 4.
- insiderSchwendenman Andrew
Chief Accounting Officer who sold 7,632 shares in an open-market transaction.
